BSE Live
Oct 29, 16:01Prev. Close
1328.25
Open Price
1364.45
Bid Price (Qty.)
1330.00 (75)
Offer Price (Qty.)
1350.00 (31)
NSE Live
Oct 29, 14:35Prev. Close
1326.00
Open Price
1341.30
Bid Price (Qty.)
1342.30 (21)
Offer Price (Qty.)
1343.00 (7)
| Balance Sheet of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 180.85 | 180.85 | 180.85 | 180.85 | 180.85 | |
| Total Share Capital | 180.85 | 180.85 | 180.85 | 180.85 | 180.85 | |
| Reserves and Surplus | 1,733.70 | 1,596.66 | 1,229.72 | 1,046.06 | 906.69 | |
| Total Reserves and Surplus | 1,733.70 | 1,596.66 | 1,229.72 | 1,046.06 | 906.69 | |
| Total Shareholders Funds | 1,914.55 | 1,777.51 | 1,410.57 | 1,226.91 | 1,087.55 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 453.87 | 442.39 | 407.58 | 453.02 | 409.11 | |
| Deferred Tax Liabilities [Net] | 32.13 | 42.40 | 0.00 | 0.00 | 80.49 | |
| Other Long Term Liabilities | 60.50 | 16.32 | 19.20 | 14.40 | 14.09 | |
| Long Term Provisions | 30.37 | 25.64 | 23.93 | 11.10 | 8.98 | |
| Total Non-Current Liabilities | 576.87 | 526.73 | 450.72 | 478.52 | 512.68 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 560.93 | 543.28 | 510.39 | 386.23 | 364.39 | |
| Trade Payables | 438.62 | 323.52 | 343.48 | 221.98 | 271.94 | |
| Other Current Liabilities | 341.98 | 371.74 | 382.99 | 350.85 | 329.67 | |
| Short Term Provisions | 38.26 | 34.79 | 30.97 | 43.25 | 35.19 | |
| Total Current Liabilities | 1,379.78 | 1,273.33 | 1,267.82 | 1,002.31 | 1,001.19 | |
| Total Capital And Liabilities | 3,871.20 | 3,577.57 | 3,129.10 | 2,707.73 | 2,601.41 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 1,095.80 | 1,019.49 | 805.10 | 764.77 | 808.70 | |
| Intangible Assets | 70.26 | 80.43 | 86.72 | 86.01 | 81.23 | |
| Capital Work-In-Progress | 326.06 | 405.96 | 469.09 | 288.43 | 71.34 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 29.62 | 0.00 | |
| Fixed Assets | 1,492.12 | 1,505.88 | 1,360.92 | 1,168.84 | 961.27 | |
| Non-Current Investments | 407.71 | 310.57 | 305.01 | 298.10 | 290.63 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 60.64 | 89.69 | 0.00 | |
| Long Term Loans And Advances | 73.25 | 66.26 | 58.65 | 56.35 | 234.59 | |
| Other Non-Current Assets | 90.56 | 56.56 | 87.51 | 90.76 | 8.05 | |
| Total Non-Current Assets | 2,063.64 | 1,939.27 | 1,872.73 | 1,703.74 | 1,494.53 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 443.66 | 495.65 | 476.44 | 547.04 | 512.93 | |
| Trade Receivables | 1,138.29 | 910.11 | 532.17 | 352.79 | 461.67 | |
| Cash And Cash Equivalents | 39.22 | 28.50 | 54.14 | 17.04 | 38.12 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 86.32 | |
| OtherCurrentAssets | 186.40 | 204.04 | 193.62 | 87.12 | 7.84 | |
| Total Current Assets | 1,807.57 | 1,638.30 | 1,256.37 | 1,003.99 | 1,106.88 | |
| Total Assets | 3,871.20 | 3,577.57 | 3,129.10 | 2,707.73 | 2,601.41 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 52.35 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 146.83 | 103.02 | 120.54 | 142.91 | 139.59 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 1,009.01 | 1,766.61 | 1,158.22 | 1,012.57 | 1,106.30 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 407.71 | 310.57 | 305.01 | 298.10 | 290.63 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
17.07.2025
10.07.2025
07.07.2025
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y
23.05.2025
Emcure Pharmace Standalone March 2025 Net Sales at Rs 1,278.19 crore, up 41.62% Y-o-Y
12.02.2025
Emcure Pharmace Standalone December 2024 Net Sales at Rs 1,028.81 crore, up 18.23% Y-o-Y